Plain-English translation of NCT05391100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This research study is screening people who have rheumatoid arthritis to see if they've developed interstitial lung disease — a condition where the lungs become scarred and stiff, making it harder to breathe. Researchers will use chest X-rays, blood tests, breathing function tests, and questionnaires to detect lung involvement early. The goal is to understand how common this lung problem is in people with rheumatoid arthritis and to create a registry of data that will help doctors better understand and treat this complication.
Lung disease is a serious complication that affects many people with rheumatoid arthritis and can contribute to disability and death, yet it often goes undiagnosed until it's advanced. This study aims to detect lung problems earlier and gather information that could improve how doctors screen for and manage this condition.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic for testing that includes chest X-rays, blood draws, and breathing function tests (where you blow into a machine to measure how well your lungs work). You'll also complete questionnaires about your quality of life and sleep patterns. This is a long-term study that follows patients over time, so you may have follow-up visits to monitor whether any lung changes develop. The entire process is non-invasive and designed to screen for problems early.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Hungary
Sponsor
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Collaborators
Medical Imaging Centre- Semmelweis University, Faculty of Medicine, Department of Pulmonology, Semmelweis University Faculty of Medicine
Enrollment target
~500 participants
Started
February 2022
Primary completion
December 2026
Age range
40 Years and older
Last updated on clinicaltrials.gov in May 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kinga Fritsch, MD
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.